Fisher D G, Schwartz P H, Davis A L
Division of Pediatric Critical Care, Memorial Miller Children's Hospital, Long Beach, CA 90801.
Crit Care Med. 1993 Jan;21(1):111-7. doi: 10.1097/00003246-199301000-00021.
This study was designed to determine the steady-state plasma concentrations and clearance rates of epinephrine in critically ill children, to examine if epinephrine pharmacokinetics conform to a linear model, and to compare epinephrine clearance rates with clearance rates of dopamine and dobutamine.
This study was prospective, without intervention or control groups.
The pediatric ICUs of two tertiary care teaching hospitals.
All patients who were hemodynamically stable while requiring continuous epinephrine infusions were eligible for the study.
Blood samples were taken at steady state and analyzed for epinephrine concentrations, as well as dopamine and dobutamine concentrations, if present, by high-pressure liquid chromatography with electrochemical detection.
Plasma epinephrine concentrations during steady-state infusions of 0.03 to 0.2 micrograms/kg/min ranged from 670 to 9430 pg/mL (3660 to 51,490 pmol/L), with a mean of 4360 +/- 3090 pg/mL (23,810 +/- 16,870 pmol/L) and were linearly related to dose. Epinephrine clearance rates ranged from 15.6 to 79.2 mL/kg/min (mean 29.3 +/- 16.1) and were not dependent on steady-state plasma concentrations. Epinephrine clearance rate was in the same range as the clearance rates of dopamine (34.1 +/- 16.6) and dobutamine (35.9 +/- 27.8) and was linearly related to them (p < .005).
Epinephrine infusions produce pharmacologic plasma concentrations of epinephrine in critically ill children. The plasma concentration of epinephrine correlates with the infusion rate, suggesting linear pharmacokinetics. Epinephrine clearance rates in critically ill children appear to be lower than the reported clearance rates in healthy adults. The clearance rates of two other inotropic catecholamines, dopamine and dobutamine, are significantly correlated with the clearance rate of epinephrine.
本研究旨在确定危重症儿童肾上腺素的稳态血浆浓度和清除率,检验肾上腺素药代动力学是否符合线性模型,并比较肾上腺素清除率与多巴胺和多巴酚丁胺的清除率。
本研究为前瞻性研究,无干预组或对照组。
两家三级护理教学医院的儿科重症监护病房。
所有血流动力学稳定且需要持续输注肾上腺素的患者均符合研究条件。
在稳态时采集血样,采用电化学检测的高压液相色谱法分析肾上腺素浓度,以及多巴胺和多巴酚丁胺浓度(如果存在)。
在以0.03至0.2微克/千克/分钟的速度稳态输注肾上腺素期间,血浆肾上腺素浓度范围为670至9430皮克/毫升(3660至51490皮摩尔/升),平均为4360±3090皮克/毫升(23810±16870皮摩尔/升),且与剂量呈线性相关。肾上腺素清除率范围为15.6至79.2毫升/千克/分钟(平均29.3±16.1),且不依赖于稳态血浆浓度。肾上腺素清除率与多巴胺(34.1±16.6)和多巴酚丁胺(35.9±27.8)的清除率处于同一范围,且与它们呈线性相关(p<0.005)。
在危重症儿童中,输注肾上腺素可产生药理学血浆浓度的肾上腺素。肾上腺素血浆浓度与输注速率相关,提示线性药代动力学。危重症儿童的肾上腺素清除率似乎低于健康成年人报告的清除率。另外两种正性肌力儿茶酚胺多巴胺和多巴酚丁胺的清除率与肾上腺素清除率显著相关。